These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 30430199)

  • 21. Targeted inhibition of T-cell factor activity promotes syndecan-2 expression and sensitization to doxorubicin in osteosarcoma cells and bone tumors in mice.
    Dieudonné FX; Marion A; Marie PJ; Modrowski D
    J Bone Miner Res; 2012 Oct; 27(10):2118-29. PubMed ID: 22550000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Sensitivity of doxorubicin-resistant osteosarcoma cells to doxorubicin regulated by long non-coding RNA NR_036444].
    Zhu KP; Zhang CL
    Zhonghua Zhong Liu Za Zhi; 2017 Apr; 39(4):250-255. PubMed ID: 28550663
    [No Abstract]   [Full Text] [Related]  

  • 23. Reversing Multidrug Resistance in Chemo-resistant Human Lung Adenocarcinoma (A549/DOX) Cells by Algerian Propolis Through Direct Inhibiting the P-gp Efflux-pump, G0/G1 Cell Cycle Arrest and Apoptosis Induction.
    Kebsa W; Lahouel M; Rouibah H; Zihlif M; Ahram M; Abu-Irmaileh B; Mustafa E; Al-Ameer HJ; Al Shhab M
    Anticancer Agents Med Chem; 2018; 18(9):1330-1337. PubMed ID: 30088453
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Extracellular matrix induces doxorubicin-resistance in human osteosarcoma cells by suppression of p53 function.
    Harisi R; Dudas J; Nagy-Olah J; Timar F; Szendroi M; Jeney A
    Cancer Biol Ther; 2007 Aug; 6(8):1240-6. PubMed ID: 17703109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Delivery of MutT homolog 1 inhibitor by functionalized graphene oxide nanoparticles for enhanced chemo-photodynamic therapy triggers cell death in osteosarcoma.
    Huang X; Chen J; Wu W; Yang W; Zhong B; Qing X; Shao Z
    Acta Biomater; 2020 Jun; 109():229-243. PubMed ID: 32294550
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pioglitazone modulates doxorubicin resistance in a in vivo model of drug resistant osteosarcoma xenograft.
    Natarajan A; Ramachandran B; Gopisetty G; Jayavelu S; Sundersingh S; Rajkumar T
    Naunyn Schmiedebergs Arch Pharmacol; 2021 Feb; 394(2):361-371. PubMed ID: 33015747
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced Stim1 expression is associated with acquired chemo-resistance of cisplatin in osteosarcoma cells.
    Sun X; Wei Q; Cheng J; Bian Y; Tian C; Hu Y; Li H
    Hum Cell; 2017 Jul; 30(3):216-225. PubMed ID: 28326487
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of CACNA1H attenuates doxorubicin-induced acute cardiotoxicity by affecting endoplasmic reticulum stress.
    Hu J; Wu Q; Wang Z; Hong J; Chen R; Li B; Hu Z; Hu X; Zhang M
    Biomed Pharmacother; 2019 Dec; 120():109475. PubMed ID: 31580970
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeting ABCB1 and ABCC1 with their Specific Inhibitor CBT-1® can Overcome Drug Resistance in Osteosarcoma.
    Fanelli M; Hattinger CM; Vella S; Tavanti E; Michelacci F; Gudeman B; Barnett D; Picci P; Serra M
    Curr Cancer Drug Targets; 2016; 16(3):261-74. PubMed ID: 26548759
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Endoplasmic reticulum stress: major player in size-dependent inhibition of P-glycoprotein by silver nanoparticles in multidrug-resistant breast cancer cells.
    Gopisetty MK; Kovács D; Igaz N; Rónavári A; Bélteky P; Rázga Z; Venglovecz V; Csoboz B; Boros IM; Kónya Z; Kiricsi M
    J Nanobiotechnology; 2019 Jan; 17(1):9. PubMed ID: 30670028
    [TBL] [Abstract][Full Text] [Related]  

  • 31. H2S-Donating Doxorubicins May Overcome Cardiotoxicity and Multidrug Resistance.
    Chegaev K; Rolando B; Cortese D; Gazzano E; Buondonno I; Lazzarato L; Fanelli M; Hattinger CM; Serra M; Riganti C; Fruttero R; Ghigo D; Gasco A
    J Med Chem; 2016 May; 59(10):4881-9. PubMed ID: 27120394
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Liposome-encapsulated doxorubicin reverses drug resistance by inhibiting P-glycoprotein in human cancer cells.
    Riganti C; Voena C; Kopecka J; Corsetto PA; Montorfano G; Enrico E; Costamagna C; Rizzo AM; Ghigo D; Bosia A
    Mol Pharm; 2011 Jun; 8(3):683-700. PubMed ID: 21491921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Induction of ER stress protects gastric cancer cells against apoptosis induced by cisplatin and doxorubicin through activation of p38 MAPK.
    Feng R; Zhai WL; Yang HY; Jin H; Zhang QX
    Biochem Biophys Res Commun; 2011 Mar; 406(2):299-304. PubMed ID: 21320468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reversal of multidrug-resistance using Valspodar (PSC 833) and doxorubicin in osteosarcoma.
    Cagliero E; Ferracini R; Morello E; Scotlandi K; Manara MC; Buracco P; Comandone A; Baroetto Parisi R; Baldini N
    Oncol Rep; 2004 Nov; 12(5):1023-31. PubMed ID: 15492788
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting ABCB1 (MDR1) in multi-drug resistant osteosarcoma cells using the CRISPR-Cas9 system to reverse drug resistance.
    Liu T; Li Z; Zhang Q; De Amorim Bernstein K; Lozano-Calderon S; Choy E; Hornicek FJ; Duan Z
    Oncotarget; 2016 Dec; 7(50):83502-83513. PubMed ID: 27835872
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Arsenic trioxide inhibits the growth of adriamycin resistant osteosarcoma cells through inducing apoptosis.
    Zhao H; Guo W; Peng C; Ji T; Lu X
    Mol Biol Rep; 2010 Jun; 37(5):2509-15. PubMed ID: 19701692
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Alopecurone B reverses doxorubicin-resistant human osteosarcoma cell line by inhibiting P-glycoprotein and NF-kappa B signaling.
    Xia YZ; Ni K; Guo C; Zhang C; Geng YD; Wang ZD; Yang L; Kong LY
    Phytomedicine; 2015 Mar; 22(3):344-51. PubMed ID: 25837271
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Experimental models for the study of drug resistance in osteosarcoma: P-glycoprotein-positive, murine osteosarcoma cell lines.
    Takeshita H; Gebhardt MC; Springfield DS; Kusuzaki K; Mankin HJ
    J Bone Joint Surg Am; 1996 Mar; 78(3):366-75. PubMed ID: 8613443
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple pathways are involved in drug resistance to doxorubicin in an osteosarcoma cell line.
    Rajkumar T; Yamuna M
    Anticancer Drugs; 2008 Mar; 19(3):257-65. PubMed ID: 18510171
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Application of tumor-targeting peptide-decorated polypeptide nanoparticles with doxorubicin to treat osteosarcoma.
    Qiu R; Sun D; Bai Y; Li J; Wang L
    Drug Deliv; 2020 Nov; 27(1):1704-1717. PubMed ID: 33305647
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.